The Care Quality Commission (CQC) has published its annual review of the management of controlled drugs in England. The report looks at the performance of those managing controlled drugs in England under the Controlled Drugs (Supervision of Management and Use) Regulations 2013 and make recommendations for the future.
- Prescribers should ask patients about their existing prescriptions and
current medicines when prescribing controlled drugs. Where possible,
prescribers should also inform the patient’s GP to make them aware of
treatment to minimise the risk of overprescribing that could lead to harm.
- Commissioners of health and care services should include the governance
and reporting of concerns around controlled drugs as part of the
commissioning and contracting arrangements so that these are not
- Healthcare professionals should keep their personal identification badges
and passwords secure and report any losses as soon as possible to
enable organisations to take the necessary action.
- Health and care staff should consider regular monitoring and auditing
arrangements for controlled drugs in the lower schedules, such as
Schedules 4 and 5, to identify and take swift action on diversion.